New Japanese Regenerative Medicine Legislation and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
New Japanese Regenerative Medicine Legislation and Commercial Opportunities for Stem Cell Products

NEW YORK and MELBOURNE, Australia, Nov. 25, 2013 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX: MSB; USOTC: MBLTY) today gave an update on new legislation which provides a framework for accelerated approval of stem cell products in Japan, the world's second-largest mature healthcare market.



Japan's parliament, the Diet, enacted a Bill last week which revised the existing Pharmaceutical Affairs Law to define new medical products which contain stem cells to be termed regenerative medicine products. The Bill allows the Japanese Government to give conditional approval to such products if their safety is confirmed in clinical trials, as may occur on completion of Phase 2.  

 

Chief Executive Silviu Itescu discussed how the new legislation in Japan could positively impact the Company, during an interview with Inside Business on ABC-TV yesterday.  To view the interview, please visit: http://www.abc.net.au/insidebusiness/

 

As a result of the new legislation, a pathway now exists in Japan for Mesoblast to commercialize its mesenchymal lineage stem and precursor cell products within a significantly shorter timeframe.  Mesoblast intends to establish strategic partnerships for its suite of products to facilitate earlier Japanese regulatory approvals and commercial launches.

 

Mesoblast's first strategic partnership in Japan is with JCR Pharmaceuticals for its culture-expanded mesenchymal stem cell (MSC) product to treat steroid refractory graft-versus-host disease.  JCR intends to file for Japanese marketing approval of its MSC product JR-031 before the end of the first quarter 2014 under the existing regulatory framework.  If the filing is successful, JR-031 will be the first allogeneic or 'off-the-shelf' cell-based product approved in Japan.

 

About Mesoblast

Mesoblast Limited (ASX: MSB; USOTC: MBLTY) is a world leader in the development of biologic products for the broad field of regenerative medicine. The Company's proprietary technologies include its Mesenchymal Precursor Cell and culture-expanded Mesenchymal Stem Cell technology platforms, Dental Pulp Stem Cells and expanded Hematopoietic Stem Cells. Mesoblast's allogeneic or 'off-the-shelf' regenerative medicine products are being developed for the treatment of conditions with significant unmet medical needs. The lead product candidates use its mesenchymal lineage cells in four major and distinct areas - systemic inflammatory conditions, cardiovascular diseases, orthopedic diseases of the spine, and oncology conditions. www.mesoblast.com

CONTACT:Julie Meldrum Global Head of Corporate Communications Mesoblast Limited T: +61 (0) 3 9639 6036 E: julie.meldrum@mesoblast.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LBT Unveils Game-Changing Cyclotron for Medical Advances

Updated Category News Views 0

Unveiling the LB-30 Cyclotron at EANM 2026 Life in nuclear medicine never stands still, and once again, Longevous Beamtech (LBT) is stirring the pot with its brand-new LB-30 series medical cyclotron. They rolled out this high-powered beast at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM 2026) in Vienna. Leaning into the 30 MeV energy...

Continue Reading
Coastal Financial Faces Lawsuit Over Fraud Allegations

Updated Category News Views 3

Coastal Financial Corporation, riding high on NASDAQ as CCB, now finds itself in the middle of a storm. Schall, Brown & Schwartz LLP, a firm known for its shareholder rights litigation, has thrown the gauntlet with a class action lawsuit against Coastal for suspected securities violations. We're talking about potential fibs under Section 10(b) and 20(a) of the Securities...

Continue Reading
Spooky Suds: House of Horror Meets El Car Wash

Updated Category News Views 7

A Haunted Wash Awaits Miami Drivers Picture this: you're cruising down West Flagler on a regular Wednesday evening, but tonight, you're not just rolling in for a rinse. Nope, this Wednesday night, the wash tunnel at El Car Wash gets downright spooky. It's getting a haunted house makeover with scare actors from the House of Horror. When a Car Wash Becomes a Haunted...

Continue Reading
OppFi Readies Q3 Earnings; Investors Eye Financials

Updated Category News Views 1

What's Unfolding at OppFi? Mark your calendars, folks. October 28th is the day OppFi (NYSE: OPFI) pulls the curtain back on its third-quarter 2026 earnings. For the uninitiated, we're talking about a tech-driven finance platform that's been making waves by providing financial solutions for everyday Americans. And you bet we're all ears for what those numbers say. Details...

Continue Reading
BETR's Legal Clash: Investor Action Deadline Nears

Updated Category News Views 0

BETR's Woes in the Legal Spotlight Investors who’ve been keeping an eye on Better Home & Finance Holding Company—trading as BETR on NASDAQ—might wanna pinch themselves. Not every day do you see a class action lawsuit waiting on the horizon like this one. The folks over at Schall, Brown & Schwartz LLP, those wily veterans in shareholder rights litigation, are...

Continue Reading
Workday Hits High Note in 2026 Gartner Magic Quadrant

Updated Category News Views 3

Workday Secures Leadership Position In a wild ride that's left investors with whiplash in recent years, Workday (NASDAQ: WDAY) has firmly planted its flag at the top tier of the 2026 Gartner® Magic Quadrant™ for Cloud ERP Finance. This announcement out of Pleasanton, California, resonates like a victory bell for the company's finance management solutions—a mix of AI,...

Continue Reading
Navigating AI Laws: A New Era for Privacy & Security

Updated Category News Views 10

Crucial Insights from the Convergence Conference Rich with intrigue, the privacy and AI governance game just upped its stakes. If there ever was a time to listen closely, it's now, people. With over 150 laws sprouting up faster than weeds, businesses are getting squeezed to keep their artificial ducks in a row. Last month over in New York, some big names in law and...

Continue Reading
D2L Ventures into Vietnam with Van Lang Alliance

Updated Category News Views 1

Unlocking New Frontiers in Vietnam's Education Well, looks like D2L is rolling into Vietnam with the kind of gusto you'd expect from a company that fancies itself a trailblazer in learning tech. This ain't just another humdrum expansion story; it's a five-year handshake with Van Lang Education Group that's got the tech firm dropping its anchor in a fresh and promising...

Continue Reading
Ryan Stills: Vegan Powerlifter Defies Odds, Wins Sixth World Title

Updated Category News Views 1

Ryan Stills: A Comeback Story for the Ages Ryan Stills isn't just lifting weights; he's lifting the entire perception of what's possible after a heavy surgical setback. We're talking about a guy who stared down a hemi-shoulder replacement—a career ender for many—and came out the other side with a whole new set of gold medals. Two years ago, some might have written him...

Continue Reading
Endava Faces Securities Fraud Lawsuit: Investor Implications

Updated Category News Views 2

Endava in Hot Water Over Alleged Misleading Statements Alright, folks, gather around—there's a storm brewing over at Endava with shareholders mightier than the Greek gods, furrowing their brows with intent. You see, Schall, Brown & Schwartz LLP, a firm that practically eats legal challenges for breakfast, is beating the drums of a securities fraud lawsuit. Yep, I'm...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Can Take Action in Spire Global Legal Proceedings

Updated Category News Views 67

Understanding the Spire Global, Inc. Lawsuit The Rosen Law Firm, recognized for its commitment to investor rights, is reaching out to those who purchased securities of Spire Global, Inc. (NYSE: SPIR). This communication pertains to a significant opportunity for investors who were involved between the initial purchase date of March 6, 2024, and the concluding date of...

Continue Reading
Restaurant Industry Bolsters Safety with New Guide

Updated Category News Views 14

There’s a fresh playbook hitting the shelves, and it’s aimed at the heart of the dining world—a guide that tackles the nasty curveballs of public safety incidents. Restaurants, the places we count on for warm meals and cold drinks, aren’t just about what’s on the menu; they're about keeping folks safe, too. The National Restaurant Association just dropped a new...

Continue Reading
XPPen Delights Attendees with Innovative Art Showcase in Paris

Updated Category News Views 125

Captivating Digital Art Experience at Japan Expo XPPen, a leading name in digital art innovation, recently captivated audiences at Japan Expo Paris 2025. This exciting event, held at the Paris Nord Villepinte Exhibition Center, hosted an incredible atmosphere filled with anticipation, as organizers expected between 225,000 and 235,000 visitors eager to explore the latest...

Continue Reading
Unlocking Potential: New Data Science Institute Premieres

Updated Category News Views 133

Albert Einstein College of Medicine Introduces Data Science Institute Leveraging the power of data is increasingly crucial in scientific and medical research, especially for institutions aiming to foster innovation and improve healthcare outcomes. Recently, Albert Einstein College of Medicine has unveiled its new Data Science Institute, a state-of-the-art facility...

Continue Reading
BioVaxys Converts Debentures Strengthening Funding for Growth

Updated Category News Views 137

BioVaxys Completes Debenture Conversions to Fuel Development BioVaxys Technology Corp. announces a significant move with the conversion of its outstanding unsecured convertible debentures. This strategic decision, influenced by recent communications from immediate holders of these debentures, marks an important step for the company as it enhances its operational funding....

Continue Reading